OMJJARA
"OMJJARA" is a word mark owned by GlaxoSmithKline LLC, filed at the CIPO on June 15, 2022. It is registered and covers classes 5, 42 and 44.
- Status
- Registered
- Since April 9, 2025
- Filed
- June 15, 2022
- Registered
- April 9, 2025
- Expires
- April 9, 2035
- Application no.
- 2191873
- Registration no.
- TMA1305466
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 3 classes
Who owns OMJJARA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
GlaxoSmithKline LLC
United States
Representative
Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
What the mark covers
The products and services OMJJARA is filed for, grouped by Nice class.
Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and disorders; Biological preparations made from living tissues for the treatment of cancer; chemical preparations for medical purposes for the treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Diagnostic reagents for medical purposes; Medical diagnostic reagents, assays, and test kits for testing of body fluids; Cells protein molecules and molecular compounds, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat cancer; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of blood diseases, bone and bone marrow diseases, and cancers; Scientific research and development in the field of cancer treatment and diagnosis, medical research services; Scientific research laboratories for conducting research in the field of cancer, cancer prevention and cancer diagnosis; Medical research laboratory services; conducting clinical trials for others; conducting clinical trial for others regarding pharmaceutical preparations and drugs in the field of blood diseases, bone and bone marrow diseases, and cancers; DNA screening and analysis services for scientific research purposes
Medical diagnostic services, medical examination services, medical analysis services for cancer diagnosis and prognosis, medical care and analysis services relating to patient treatment, providing medical information in the field of cancer treatment; medical testing services; DNA screening and analysis services for medical purposes
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Registration Pending
- Advertised; Vol.72 Issue 3665
- Approval Notice Sent; APPROVED BY PROGRAM EX200M1
- Approved; APPROVED BY PROGRAM EX200M1
- Agent Changed; From/De: 5153 To/A: 4
- Correspondence Created
- Examiner's First Report
- Search Recorded
- Change of Title Registered; Assignment/Cession
10 earlier steps on the official record.
About OMJJARA
Who owns the trademark "OMJJARA"?
The CIPO trademark "OMJJARA" (application 2191873) is owned by GlaxoSmithKline LLC.
What is the status of "OMJJARA"?
Its status at the CIPO is: registered.
When was "OMJJARA" registered?
It was registered on April 9, 2025 and is due to expire on April 9, 2035.
Get this data via the API
Everything on this page comes from the Signa API. Pull OMJJARA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb1f-0faa-7307-b5d0-749c8f4f20c9
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb1f-0faa-7307-b5d0-749c8f4f20c9",
"object": "trademark",
"mark_text": "OMJJARA",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "2191873",
"filing_date": "2022-06-15",
"nice_classes": [
5,
42,
44
],
"owners": [
{
"name": "GlaxoSmithKline LLC",
"entity_id": "ent_019ebbad-4be6-7544-bafb-06b4c2a2ecb2"
}
]
}